Prognostic Impact of Helicobacter pylori Infection and Eradication Therapy in Gastric Mucosa-associated Lymphoid Tissue Lymphoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is associated with Helicobacter pylori infection and H. pylori eradication is used as its first-line therapy. However, controversies exist about the prognostic value of H. pylori infection in these patients. We evaluated the prognostic impact of H. pylori infection and eradication therapy in gastric MALT lymphoma. Methods : A total of 292 patients diagnosed with MALT lymphoma since 2000 were analysed. MALT lymphoma was diagnosed with tissue biopsy and H. pylori infection was diagnosed with hematoxylin-eosin and additional Warthin-Starry stains on tissue sections. Clinical variables such as bone marrow (BM) involvement, multiorgan involvement, tumor stage at diagnosis, and remission were obtained with retrospective review of electronic medical records. Results : Non-gastric MALT lymphoma patients showed higher multiorgan involvement rates (26.6% vs. 9.6%, P<0.001) and higher proportion of stage ≥3 (27.7% vs. 16.7%, P=0.029) than gastric cases. Regarding gastric MALT lymphoma, patients with H. pylori infection at diagnosis showed significantly less BM (2.1% vs. 21.8%, P<0.001) and multiorgan involvement rates (6.3% vs. 18.2%, P=0.011) than those without infection. But there was no significant difference in remission rates between them. In contrast, those with successful H. pylori eradication therapy showed significantly higher remission rates (81.0% vs. 30.8%, P<0.001) than those with failure. Conclusions : Non-gastric MALT lymphoma patients showed worse prognosis compared to gastric cases. As for remission rates in patients with gastric MALT lymphoma, successful H. pylori eradication therapy could be a good prognostic factor even if H. pylori infection was present at diagnosis. (Korean J Lab Med 2010;30:547-53)
Abstract
Background : Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is associated with Helicobacter pylori infection and H. pylori eradication is used as its first-line therapy. However, controversies exist about the prognostic value of H. pylori infection in these patients. We evaluated the prognostic impact of H. pylori infection and eradication therapy in gastric MALT lymphoma. Methods : A total of 292 patients diagnosed with MALT lymphoma since 2000 were analysed. MALT lymphoma was diagnosed with tissue biopsy and H. pylori infection was diagnosed with hematoxylin-eosin and additional Warthin-Starry stains on tissue sections. Clinical variables such as bone marrow (BM) involvement, multiorgan involvement, tumor stage at diagnosis, and remission were obtained with retrospective review of electronic medical records. Results : Non-gastric MALT lymphoma patients showed higher multiorgan involvement rates (26.6% vs. 9.6%, P<0.001) and higher proportion of stage ≥3 (27.7% vs. 16.7%, P=0.029) than gastric cases. Regarding gastric MALT lymphoma, patients with H. pylori infection at diagnosis showed significantly less BM (2.1% vs. 21.8%, P<0.001) and multiorgan involvement rates (6.3% vs. 18.2%, P=0.011) than those without infection. But there was no significant difference in remission rates between them. In contrast, those with successful H. pylori eradication therapy showed significantly higher remission rates (81.0% vs. 30.8%, P<0.001) than those with failure. Conclusions : Non-gastric MALT lymphoma patients showed worse prognosis compared to gastric cases. As for remission rates in patients with gastric MALT lymphoma, successful H. pylori eradication therapy could be a good prognostic factor even if H. pylori infection was present at diagnosis. (Korean J Lab Med 2010;30:547-53)
참고문헌 (31)
- Isaacson P, "Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma", Cancer, 52, pp.1410~1416 (1983)
- Harris NL, "A revised European-American classification of lymphoid neoplasms:a proposal from the International Lymphoma Study Group", Blood, 84, pp.1361~1392 (1994)
- Swerdlow SH, "WHO classification of tumours of hematopoietic and lymphoid tissues" (2008), Lyon
- Cohen SM, "Non-Hodgkin’s lymphoma of mucosa-associated lymphoid tissue", Oncologist, 11, pp.1100~1117 (2006)
- Inamdar KV, "Bone marrow involvement by marginal zone B-cell lymphomas of different types", Am J Clin Pathol, 129, pp.714~722 (2008)
- Ko YH, "REAL classification of malignant lymphomas in the Republic of Korea:incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma", Cancer, 83, pp.806~812 (1998)
- Raderer M, "High relapse rate in patients with MALT lymphoma warrants lifelong follow-up", Clin Cancer Res, 11, pp.3349~3352 (2005)
- Eidt S, "Helicobacter pylori gastritis and primary gastric non-Hodgkin’s lymphomas", J Clin Pathol, 47, pp.436~439 (1994)
- Wotherspoon AC, "Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma", Lancet, 338, pp.1175~1176 (1991)
- Nakamura S, "Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients", Cancer, 79, pp.3~11 (1997)
- Karat D, "Prospective study of Helicobacter pylori infection in primary gastric lymphoma", Br J Surg, 82, pp.1369~1370 (1995)
- Bayerdörffer E, "Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group", Lancet, 345, pp.1591~1594 (1995)
- Roggero E, "Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue", Ann Intern Med, 122, pp.767~769 (1995)
- Savio A, "Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term posttreatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol’s adequacy", Recent Results Cancer Res, 156, pp.116~124 (2000)
- Wotherspoon AC, "Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori", Lancet, 342, pp.575~577 (1993)
- Park IS, "Helicobacter pylori infection in Korea", Yonsei Med J, 42, pp.457~470 (2001)
- Raderer M, "Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience", J Clin Oncol, 24, pp.3136~3141 (2006)
- Papaxoinis G, "Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)", Ann Oncol, 19, pp.780~786 (2008)
- Kalpadakis C, "Kontopidou FN, et al. Non-gastric extra-nodal marginal zone lymphomas--a single centre experience on 76 patients", Leuk Lymphoma, 49, pp.2308~2315 (2008)
- Oh SY, "Nongastric marginal zone B-cell lymphoma: analysis of 247 cases", Am J Hematol, 82, pp.446~452 (2007)
- Terai S, "Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy", Tohoku J Exp Med, 214, pp.79~87 (2008)
- Cho EY, "Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients", Am J Hematol, 73, pp.87~96 (2003)
- Lee JL, "Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa", Ann Hematol, 84, pp.13~18 (2005)
- Raderer M, "Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma", Br J Cancer, 83, pp.454~457 (2000)
- Chung SJ, "Longterm clinical outcome of Helicobacter pylori-negative gastric mucosaassociated lymphoid tissue lymphoma is comparable to that of H. pylori-positive lymphoma", J Clin Gastroenterol, 43, pp.312~317 (2009)
- Akamatsu T, "Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection", Helicobacter, 11, pp.86~95 (2006)
- Arcaini L, "Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination", Oncologist, 11, pp.285~291 (2006)
- Kurtin PJ, "Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type", Am J Surg Pathol, 25, pp.997~1008 (2001)
- Steinbach G, "Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial", Ann Intern Med, 131, pp.88~95 (1999)
- 김수진, "위 MALT 림프종에서 Helicobacter pylori 제균에 의한 완전 관해 예측인자", 대한소화기학회지, 55(2), pp.94~99 (2010), 대한소화기학회
- Kim JS, "Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease", Br J Cancer, 96, pp.1324~1328 (2007)